Colchicine (CID: 6167), the pharmacological control for this study, lowers inflammation and infarct size.52, 53 However, unadjusted colchicine doses, particularly when combined with CYP3A4 inhibitors, have killed chronic renal insufficiency patients. Here, CYP3A4 is linked to chronic kidney disease.